Paper Details

Paper Title

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases.

Paper Journal Title

ACS Med Chem Lett

Paper Citation Count

Paper Publication Year

2017

Bio Mention

A, A-485, CBP, HAT, Histone Acetyltransferases, Spiro Oxazolidinediones, cancer, fluoro, histone acetyltransferase, histones, hydantoin, oxazolidinedione, p300

Mesh Descriptor

Author Name	Affiliation
Philip A Cole	Inc.
Ronen Marmorstein	Inc.
Kenneth D Bromberg	Inc.

1 - 3

Paper Details

Column Actions

Datasets